Webcast CME

Resuscitating a Dying Marrow:
Emerging Concepts and Treatment
Advances in Myeloid Malignancies Webcasts

Emerging Concepts and Treatment Advances in Myeloid Malignancies Case-Based Discussion

Print this Content

Release date: January 17, 2022
Expiration date: January 17, 2024

Estimated Time of Completion: 45 minutes

Description

The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.

Learning Objectives

  1. Detail the emerging concepts and treatment advances in myeloid malignancies case-based discussion.

Target Audience

The virtual satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS, AML and myeloid malignancies. In addition, members of patient advocacy groups will benefit from this program.

Accreditation

In support of improving patient care, this activity has been planned and implemented by Cleveland Clinic Center for Continuing Education and Aplastic Anemia & MDS International Foundation. Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

American Medical Association (AMA)

Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

American Nurses Credentialing Center (ANCC)

Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 0.75 ANCC contact hours.

American Academy of PAs (AAPA)

Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Certificate of Participation

A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations

Activity Director and Faculty

Activity Director

Bhumika Patel, MD
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH

Sudipto Mukherjee, MD, PhD, MPH
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH

Faculty

Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia, Division of Cancer Medicine,
The University of Texas MD Anderson Cancer Center
Houston, TX

Antonio Risitano, MD, PhD
Head of the Clinical Unit of Hematopoietic Stem Cell Transplantation, Hematology, Department of Biochemistry and Medical Biotechnologies
University of Naples
Naples, Italy 

Yogen Saunthararajah, MD
Hematology and Medical Oncology
Cleveland Clinic Main Campus
Clevleand, Ohio 

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias. 

The following faculty member has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Sudipto Mukherjee, MD
Aplastic Anemia and MDS International Foundation Honorarium - Activity Director of ASH Friday Satellite Symposium 2020
Eusa Pharma Consulting
Advisor or review panel participant
Teaching and Speaking
Novartis Consulting
Research / Independent Contractor
Advisor or review panel participant
McGraw Hill Honoraria - Editor of Hematology Oncology Board Review (ongoing)
Bristol-Myers Squibb Co. Advisor or review panel participant
Honoraria
Celgene Corporation Board Membership
Consulting
Research / Independent Contractor
Advisor or review panel participant
Research Funding - non-therapeutic investigator trials. Formerly Celgene (now BMS)

Naveen Pemmaraju, MD
Pacylex Pharmaceuticals Consulting
ImmunoGen, Inc Consulting
Bristol-Myers Squibb Co. Consulting
Blueprint Medicines Consulting
Clearview Healthcare Partners Consulting
Protagonist Therapeutics, Inc. Consulting
Affymetrix Consulting
Incyte Consulting
Novartis Pharmaceuticals Consulting
Research support.
LFB Biotechnologies Consulting
Stemline Therapeutics, Inc. Consulting
Advisor or review panel participant.
Research support.
Celgene Corporation Consulting
Abbvie Pharmaceuticals Consulting
Advisor or review panel participant.
Research support.
MustangBio Consulting
Research support.
Roche Diagnostics Consulting
DAVA Oncology Consulting
Springer Science + Business Media Invited authorship.
Aptitude Health Consulting
CareDx, Inc. Consulting
Cellectis S.A. ADR Research support.
Daiichi Sankyo, Inc. Research support.
Plexxicon Research support.
Samus Research support.
ASH Communications Committee Board Membership
ASCO Leukemia Advisory Panel Board Membership
Advisor or review panel participant.
HemOnc Times/Oncology Times Board Membership
Dan's House of Hope Board Membership

Antonio Risitano, MD
Alexion Board Membership
Teaching and Speaking
Apellis Pharmaceuticals Board Membership
Teaching and Speaking
Novartis Board Membership
Consulting
Research / Independent Contracto
Teaching and Speaking
Pfizer Board Membership
Research / Independent Contractor
Teaching and Speaking
BioCryst Pharmaceuticals, Inc. Board Membership
Consulting
Roche Board Membership
Consulting

Yogen Saunthararajah, MD
Epidestiny LLC Board Membership
Consulting
Intellectual property rights (Royalties or patent sales)
Ownership interest (stock, stock options in a publicly owned company)

Acknowledgement

The Aplastic Anemia and MDS International Foundation and Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this internet enduring activity from:
Alexion Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.
Ascentage Pharma Group, Inc.
Biocryst Pharmaceuticals Inc.
Bristol-Myers Squibb
Geron Corporation
Taiho Oncology
Takeda Oncology

 


This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Taussig Cancer Institute and Aplastic Anemia & MDS International Foundation.